https://dmoginhibitor.com/eluc....idation-from-the-het
We identified 5265 clients; 37% hormone receptor (HR) +/HER2 - , 19% HR +/HER2 + , 18% HR -/HER2 + , and 26% triple-negative, and 5-year general success ended up being 51.6%. Only 34% had been addressed relating to recommendations with NAC, altered radical mastectomy, and adjuvant radiation. Pathologically good lymph nodes (ypN +) after NAC diverse by subtype and clinical nodal status (cN) ranging from 82% in cN + HR +/HER2 - patients to 19% in cN0 HR -/HER2 + p
Like
Comment
Share
